首页>
外国专利>
Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor
Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor
展开▼
机译:口服给予bcl-2家族抑制剂的药物剂型
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a pharmaceutical dosage form which comprises a solid dispersion product comprising N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide or a salt, hydrate or solvate thereof, at least one pharmaceutically acceptable polymer, and at least one pharmaceutically acceptable solubilizer. The invention is further directed to processes for preparing the pharmaceutical dosage form and to use of the dosage form for treating proliferative disorders.
展开▼